Latest News

The findings suggest that health risks may occur below levels currently considered safe by the EPA's arsenic limit that was determined in 2001.

A study has shown that arsenic levels in public drinking water systems are higher in some states, which can increase the risk of low birth weight and other

Four experts were sued for defamation ahead of a seminar where they planned to talk about research into the potential health risks on playgrounds and sports fields nationwide.

In this Q&A, two Yale experts delve into the challenges posed by PFAS and potential solutions for reducing exposure and contamination.

Fluoride is a naturally occurring mineral that is commonly added to drinking water and dental products to prevent cavities, a significant public health achievement. However, prolonged exposure to high levels of fluoride can damage teeth and bones, and recent evidence suggests that moderate levels of fluoride may be linked to lower IQ in children. Balancing fluoride’s profound oral health benefits while minimizing potential harms requires a careful examination of the latest data.

Newsweek spoke to Dr. Nicole Deziel, researcher at Yale Cancer Center and associate professor of epidemiology at the Yale School of Public Health.

One of Women’s Health Research at Yale’s major initiatives is to mentor the next generation of health care professionals and researchers about the value of studying the influence of sex on health and disease as well as ensuring that findings are translated into clinical care.

A groundbreaking new database could lead to vast improvements in precision oncology by documenting sex-based differences in cancer treatment efficacy, biomarkers, risk factors, and microbial influences across 71 cancer types. The database — created by researchers at the Yale School of Public Health, Yale School of Medicine, and international collaborators — addresses a significant gap in current research and demonstrates how biological sex can comprehensively impact cancer onset, progression, and therapeutic outcomes.

The Pain Management Collaboratory Coordinating Center, a Yale-based research center that supports 16 large-scale pragmatic clinical trials of non-drug approaches to managing pain, has been awarded a funding extension to continue its work for six years.